| Followers | 9 |
| Posts | 3233 |
| Boards Moderated | 0 |
| Alias Born | 04/21/2025 |
Friday, October 31, 2025 8:25:42 AM
If you are technically correct, LP seems to have once again found a legal loophole and avoided disclosing to shareholders what she just sold to them.
Furthermore, since the deal is already closed, without NW shareholders having any idea what they bought, are you not concerned at all?
All we know so far is that LP is going to get the $8 million or so owed to Advent (which was her) and $1.4 million initial payment. We don't know the financial health of Advent (or its ability to continue as a going concern) nor do we know what the milestone payments are.
What if.... hypothetically speaking, you come to find out in January 10K that Advent has no revenue and massive liabilities? At that point it is way too late for any shareholder recourse. The fact that LP indemnified herself , employees and directors from any criminal or civil action in the latest S3 would be extremely concerning to me. To say the least.
I am not a shareholder, for these and other obvious reasons, but please tell me, are you not concerned at all, not knowing almost anything about this transaction?
I wish all involved the best of luck, there is just too much murky stuff going on with this company for my taste and my money, to date. This includes the deafening silence regarding almost 2 years into the MAA process.
Furthermore, since the deal is already closed, without NW shareholders having any idea what they bought, are you not concerned at all?
All we know so far is that LP is going to get the $8 million or so owed to Advent (which was her) and $1.4 million initial payment. We don't know the financial health of Advent (or its ability to continue as a going concern) nor do we know what the milestone payments are.
What if.... hypothetically speaking, you come to find out in January 10K that Advent has no revenue and massive liabilities? At that point it is way too late for any shareholder recourse. The fact that LP indemnified herself , employees and directors from any criminal or civil action in the latest S3 would be extremely concerning to me. To say the least.
I am not a shareholder, for these and other obvious reasons, but please tell me, are you not concerned at all, not knowing almost anything about this transaction?
I wish all involved the best of luck, there is just too much murky stuff going on with this company for my taste and my money, to date. This includes the deafening silence regarding almost 2 years into the MAA process.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
